Journals / Turkish Journal of Medical Sciences / 2005 / Cilt: 35 - Sayı: 5

TSH Levels in Turkish Adults: Prevalences and Associations With Serum Lipids, Coronary Heart Disease and Metabolic Syndrome

Pages
297–304
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Following up the group prospectively may give a better understanding concerning the thyroid status and CHD risk in Turkish adults.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Overt hypothyroidism is implicated in atherosclerosis through dyslipidemia, hypertension, and hyperhomoscysteinemia.
📊
Key Findings & Data:Thyroid stimulating hormone (TSH) was measured in the 2004 follow-up of the Turkish Adult Risk Factor Study, with the aim of investigating thyroid hormone status as a possible risk factor in CHD and MS in the population sample.
💡
Conclusion & Impact:Following up the group prospectively may give a better understanding concerning the thyroid status and CHD risk in Turkish adults.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Coronary disease risk · serum TSH · thyroid status

Abstract

Overt hypothyroidism is implicated in atherosclerosis through dyslipidemia, hypertension, and hyperhomoscysteinemia. Epidemiological data related to the role of thyroid hormones in the risk of coronary heart disease (CHD) and metabolic syndrome (MS) in Turkish adults are lacking. Thyroid stimulating hormone (TSH) was measured in the 2004 follow-up of the Turkish Adult Risk Factor Study, with the aim of investigating thyroid hormone status as a possible risk factor in CHD and MS in the population sample. To this end, a subgroup of the cohort (512 men and women: mean age 52 ± 11.4) in whom the prevalences for CHD, MS and diabetes (DM) were 8.2%, 42.4% and 10.7%, respectively, were screened for TSH. The cohort was classified as hypo-, hyper- or euthyroid according to cutoffs of 4.2 and 0.3 µU/ml for TSH, respectively. No distinction was made between overt and subclinical thyroid states. Total and LDL-cholesterol was lowest, but waist circumference unexpectedly highest in the hyperthyroid group. Women (1.3 µU/ml) had significantly higher (P < 0.001) TSH levels than men (0.95 µU/ml). The prevalence of hypo- and hyperthyoidism in men and women were 1.7%/7% and 4.4%/5%, respectively, and women overwhelmingly predominated the hypothyroid cases. TSH values did not significantly differ among groups diagnosed as or not CHD, MS, or DM. Log TSH was significantly correlated with total and LDL-cholesterol and, inversely, with alcohol usage. Multivariate linear regression analysis revealed total cholesterol as the sole independent covariate of TSH levels in men and both sexes combined. An increase by approximately one-third of the physiological TSH levels was associated with a 40 mg/dl-increase in total cholesterol concentrations. Age- and sex-adjusted TSH did not contribute to the risk of CHD, hypercholesterolemia, MS, or DM in logistic regression analyses. To conclude, TSH levels were independently associated with total cholesterol concentrations but did not appear to be a risk factor for CHD or MS in the cohort studied. Following up the group prospectively may give a better understanding concerning the thyroid status and CHD risk in Turkish adults.

Özet

Overt hypothyroidism is implicated in atherosclerosis through dyslipidemia, hypertension, and hyperhomoscysteinemia. Epidemiological data related to the role of thyroid hormones in the risk of coronary heart disease (CHD) and metabolic syndrome (MS) in Turkish adults are lacking. Thyroid stimulating hormone (TSH) was measured in the 2004 follow-up of the Turkish Adult Risk Factor Study, with the aim of investigating thyroid hormone status as a possible risk factor in CHD and MS in the population sample. To this end, a subgroup of the cohort (512 men and women: mean age 52 ± 11.4) in whom the prevalences for CHD, MS and diabetes (DM) were 8.2%, 42.4% and 10.7%, respectively, were screened for TSH. The cohort was classified as hypo-, hyper- or euthyroid according to cutoffs of 4.2 and 0.3 µU/ml for TSH, respectively. No distinction was made between overt and subclinical thyroid states. Total and LDL-cholesterol was lowest, but waist circumference unexpectedly highest in the hyperthyroid group. Women (1.3 µU/ml) had significantly higher (P < 0.001) TSH levels than men (0.95 µU/ml). The prevalence of hypo- and hyperthyoidism in men and women were 1.7%/7% and 4.4%/5%, respectively, and women overwhelmingly predominated the hypothyroid cases. TSH values did not significantly differ among groups diagnosed as or not CHD, MS, or DM. Log TSH was significantly correlated with total and LDL-cholesterol and, inversely, with alcohol usage. Multivariate linear regression analysis revealed total cholesterol as the sole independent covariate of TSH levels in men and both sexes combined. An increase by approximately one-third of the physiological TSH levels was associated with a 40 mg/dl-increase in total cholesterol concentrations. Age- and sex-adjusted TSH did not contribute to the risk of CHD, hypercholesterolemia, MS, or DM in logistic regression analyses. To conclude, TSH levels were independently associated with total cholesterol concentrations but did not appear to be a risk factor for CHD or MS in the cohort studied. Following up the group prospectively may give a better understanding concerning the thyroid status and CHD risk in Turkish adults.

🔖

Cite This Article

ONAT, A., KARABULUT, A., TÜRKMEN, S., SARI, İ., CAN, G., HERGENÇ, G., ALBAYRAK, S. (2022). TSH Levels in Turkish Adults: Prevalences and Associations With Serum Lipids, Coronary Heart Disease and Metabolic Syndrome. Turkish Journal of Medical Sciences, Cilt: 35 - Sayı: 5, 297–304. https://ajindex.com/articles/611965

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Auer J, Berent R, Weber T et al. Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin Cardiol 26:569-573, 2003.
  2. Papaioannou GI, Lagasse M, Mather JF et al. Treating hypothyroidism improves endothelial function. Metabolism 53:278-9, 2004.
  3. Demers LM, Spencer CA. Thyrotropin/thyroid stimulating hormone. In: Baloch Z et al. (eds). Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126,2003. AACE Thyroid Task Force. American Association of Clinical Endocrinologist medical guidelines for clinical practice for the evaulation and treatment of hyperthyroidism. Endocr Prac 8:457- 469, 2002.
  4. Arrivie J, Sbragia P, Denizot A et al. Cardiovascular symptoms and risks of subclinical dysthyroidism. Rev Med Interne 25:207- 216,2004. 6. Althaus BU, Staub JJ, Ryff-De Leche A et al. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf) 28:157-163,1988.
  5. Schlienger JL, Goichot B, Vinzio S et al. Sub-clinical hypothyroidism, towards the end of a controversy? Presse Med 32(37 Pt1):1760-1765, 2003
  6. Biondi B, Klein I: Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24:1-13, 2004. 9. Lindeman RD, Romero LJ, Schade DS et al. Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey. Thyroid 13:595-600, 2003.
  7. Gallistl S, Sudi KM, Leschnik B et al. Inverse correlation between thyroid function and hemostatic markers for coronary heart disease in obese children and adolescents. J Pediatr Endocrinol Metab 13:1615-20, 2000.
  8. Pirich C, Mullner M, Sinzinger H. Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J Clin Epidemiol 53:623-629, 2000.
  9. Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med 2:351-355, 2004.
  10. Vierhapper H, Nardi A, Grosser P et al. Low-density lipoprotein cholesterol in subclinical hypothyroidism. Thyroid 10:981-984, 2000.
  11. Volzke H, Robinson DM, Schminke U et al. Thyroid function and carotid wall thickness. J Clin Endocrinol Metab 89:2145-2149, 2004
  12. Parle JV, Maisonneuve P, Sheppard MC et al. Prediction of all- cause and cardiovascular mortality in the elderly people from one low serum thyrotropin